The ROE (Return on Equity) of Taro Pharmaceutical Industries Ltd (TARO) is 3.00%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-03-31 | 3.00% |
| 2023-03-31 | 1.47% |
| 2022-03-31 | 3.41% |
| 2021-03-31 | -22.70% |
| 2020-03-31 | 11.61% |
| 2019-03-31 | 14.79% |
| 2018-03-31 | 9.58% |
| 2017-03-31 | 22.07% |
| 2016-03-31 | 28.01% |
| 2015-03-31 | 34.31% |